Literature DB >> 3302210

Identification by immunoblotting of three halothane-induced liver microsomal polypeptide antigens recognized by antibodies in sera from patients with halothane-associated hepatitis.

J G Kenna, J Neuberger, R Williams.   

Abstract

Previous studies have demonstrated that sera from patients with severe liver damage after halothane anesthesia ("halothane hepatitis") contain antibodies reacting with novel antigenic determinants expressed on hepatocytes from rabbits exposed previously to halothane. To determine the structure of the halothane-induced antigen(s), immunoblotting experiments were performed using patient sera and rabbit liver subcellular fractions. Three polypeptide antigens (Mr 100,000, 76,000 and 57,000) expressed in liver fractions from animals sacrificed 16 hr after exposure to 1% halothane in oxygen for 45 min, but not in fractions from unexposed animals, were identified. Analysis of fractions prepared by differential and sucrose density gradient centrifugation, and characterized by enzyme marker analysis, localized all three antigens to a microsomal subfraction relatively enriched in glucose-6-phosphatase activity, therefore, presumably derived from the endoplasmic reticulum. Antibodies to these antigens were detected in 19 of 24 sera from patients with halothane hepatitis, and four distinct patterns of antibody specificity were observed: 100,000 + 76,000 (seven patients), 100,000 alone (seven patients), 76,000 alone (three patients) and 57,000 alone (two patients). Such antibodies were not detectable in sera from 24 normal blood donors or 36 control patients. Thus, halothane induces expression of three distinct polypeptide antigens in liver, and patients with halothane hepatitis differ in patterns of recognition of these antigens by circulating antibodies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3302210

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Retrospective study of post-anesthetic mild liver disorder associated with inhalation anesthetics, halothane and enflurane.

Authors:  Y Sakaguchi; S Inaba; Y Umeki; S Takahashi; J Yoshitake; Y Hayashi; K Akazawa; Y Nose
Journal:  J Anesth       Date:  1992-04       Impact factor: 2.078

Review 2.  Drug metabolism and hepatotoxicity.

Authors:  J M Tredger; M Davis
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 3.  Immunotoxic side-effects of drug therapy.

Authors:  J A Mitchell; E M Gillam; L A Stanley; E Sim
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

4.  Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase.

Authors:  H Satoh; B M Martin; A H Schulick; D D Christ; J G Kenna; L R Pohl
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

5.  Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. 5-7 April 1989, Bristol. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

Review 6.  Role of animal models in the study of drug-induced hypersensitivity reactions.

Authors:  Jack Uetrecht
Journal:  AAPS J       Date:  2006-01-13       Impact factor: 4.009

7.  Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis.

Authors:  N R Kitteringham; J G Kenna; B K Park
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

8.  Localization of halothane-induced antigen in situ by specific anti-halothane metabolite antibodies.

Authors:  A K Hubbard; T P Roth; S Schuman; A J Gandolfi
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

9.  Tissue acylation by the chlorofluorocarbon substitute 2,2-dichloro-1,1,1-trifluoroethane.

Authors:  J W Harris; L R Pohl; J L Martin; M W Anders
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

Review 10.  Immunoblotting and dot blotting.

Authors:  D I Stott
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.